Radiopharmacokinetic data for 99mTc-ABP - A new radiopharmaceutical for bone scanning: Comparison with 99mTc-MDP

Nuclear Medicine and Biology

Volumn 24, Issue 1, 1997, Pages 27-33

  Arteaga De Murphy, Consuelo ^a   Meléndez Alafort, Laura ^a   Montoya Molina, Carlos E ^a   Sepúlveda Méndez, Jesús ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

bone scan 99mTc alendronate; diphosphonate 99m ABP pharmacokinetics; pharmacokinetics radioactive alendronate; technetium 99mTc alendronate pharmacokinetics

Indexed keywords

ALENDRONATE TC 99M; ALENDRONIC ACID; MEDRONATE TECHNETIUM TC 99M; MEDRONIC ACID; UNCLASSIFIED DRUG; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M ALENDRONATE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BONE SCINTISCANNING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; PHARMACOKINETICS; ANIMAL; AREA UNDER THE CURVE; BLOOD; BONE; COMPARATIVE STUDY; HALF LIFE TIME; RABBIT; RAT; SCINTISCANNING; TISSUE DISTRIBUTION; WISTAR RAT;

ADULT; ALENDRONATE; ANIMALS; AREA UNDER CURVE; BONE AND BONES; FEMALE; HALF-LIFE; HUMANS; MALE; MICE; ORGANOTECHNETIUM COMPOUNDS; RABBITS; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TECHNETIUM TC 99M MEDRONATE; TISSUE DISTRIBUTION;

EID: 0030609885     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(96)00151-5     Document Type: Article

References (31)

1. Adani S., Baroni M. C., Broggini M., et al. (1993) Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin. Osteporosis Int. 3, 21-27.
2. Anderson D. C. (1993) Alendronate: Some remaining paradoxes. Osteoporosis Int. 3, 41-42.
3. Arteaga de Murphy C., Meléndez A. L., Montoya M. C. and Sepúlveda M. J. (in press) Technetium-99m-alendronate: A new radiopharmaceutical for bone scanning. Arch. Med. Res.
4. Arteaga de Murphy C. (1992) Manual de Radiofarmacocinetica, pp. 1-77. INNSZ.
5. 99mTc-labeled 1-hydroxy-ethylidene-1,1-disodiumphosphonate. J. Nucl. Med. 13, 823-827.
6. Clanton J. A. (1987) Radiopharmacokinetics in nuclear medicine. In: Essentials of Nuclear Medicine Science (Edited by Hladik W. B., Saha G. B. and Study K.T.) Williams & Wilkins, Baltimore.
7. Collier B. D., Sodee D. B. and Robinson R. G. (1995) Bone. In: Principles and Practice of Nuclear Medicine, 2nd edn. (Edited by Early P. J. and Sodee D. B.), pp. 339-361. Mosby, St. Louis.
8. DiPiro J. T., Blouin R. A., Pruemer J. M. and Spruill W. J. (1988) Concepts in Clinical Pharmacokinetics: A Self-Instructional Course. ASHP, Bethesda, MD.
9. Fleisch H. (1993) Bisphophonates in osteoporosis: An introduction. Osteoporosis Int. 3, 3-5.
10. Gertz B. J., Holland S. D., Kline W. F., Matuszewski B. K. and Porras A. G. (1993). Clinical pharmacology of alendronate sodium. Osteoporosis Int. 4, 13-16.
11. Harbert J. C. (1996) The musculoskeletal system. In: Nuclear Medicine Diagnosis and Therapy (Edited by Harbert J. C., Eckelman W. C. and Neumann R. D.), pp. 801-863. Thieme, New York.
12. Hosain P. and Wang T. S. T. (1981) Bone imaging compounds with special reference to structure-affinity relationship. In: Radiopharmaceuticals Structure-Affinity Relationships (Edited by Spencer R. P.), pp. 531-537. Grune & Stratton, New York.
13. Krishnamurthy G. T., Huebotter R. J., Tubis M. and Blahd W. H. (1976) Pharmacokinetics of current skeletal-seeking radiopharmaceuticals. Am. J. Roentgenol. 26, 293-301.
14. Krishnamurthy G. T., Tubis M., Endow J. S., Singhi V., Walsh C. F. and Blahd W. H. (1974) Clinical comparison of the kinetics of 99mTc-labeled polyphosphate and diphosphonate. J. Nucl. Med. 15, 848-855.
15. Ley de Protección de animales del D. F. (1981) Instructivo. Buen trato de animales en lo referente a experimentación cientifica en el laboratorio central de la Secretaría de Salud y Asistencia. México.
16. Meléndez A. L. (1995) Determinación indirecta de la unión de radiof ármacos en proteínas séricas como un método para el control de calidad. B.Sc. thesis México.
17. Mesquita C. H. (1995) Programa AnaComp. Version 3.12 Instituto Pesquisas Energeticas e Nucleares-IPEN. Depto. Aplicaçoes Industriais-TE. Sao Paulo, Brasil.
18. Murphy A. R. S. (1991) Programa de computacion BIEXP. Version 2.0 Instituto Nacional de Astrofisica, Optica y Electrónica, Tonanzintla, Puebla, México.
19. Murray I. P. C. (1994) Bone scintigraphy: The procedure and interpretation. In: Nuclear Medicine in Clinical Diagnosis and Treatment (Edited by Murray I. P. C. and Ell P. J.), pp. 909-934. Churchill Livingstone, New York.
20. 99m-Tc-diphosphonate (HEDSPA). Radiology 107, 557-562.
21. Rodan G. A., Seedor J. G. and Balena R. (1993) Preclinical pharmacology of alendronate. Osteoporosis Int. 3, 7-12.
22. STATGRAPHICS (1994) Manuals. Statistical Graphics Corporation, Cambridge, MA, 1993, version 7.1. Churchill Livingstone, New York.
23. Subramanian G., McAfee J. C., Thomas F. D., Feld T. A., Zaft-Longo C. and Palladino E. (1983) New diphosphonate compounds for skeletal imaging: Comparison with methylene diphosphonate. Radiology 149, 823-828.
24. Subramanian G., McAfee J. G., Blair R. J., Kallfelz F. A. and Thomas F. D. (1975) Technetium-99m-methylene diphosphonate - a superior agent for skeletal imaging: Comparison with other technetium complexes. J. Nucl. Med. 16, 744-755.
25. Subramanian G., Blair R. J., Kallfelz F. A., Thomas F. D. and McAfee J. G. (1973) 99mTc-MDP (methylene diphosphonate): A superior agent tor skeletal imaging. J. Nucl. Med. 14, 640.
26. Subramanian G., McAfee J. G., Blair R. J., Mether A. and Connor T. (1972) Tc-99m-EHDP: A potential radiopharmaceutical for skeletal imaging. J. Nucl. Med. 13, 947-950.
27. Thrall J. H. and Ziessman H. A. (1995) Skeletal system. In: Nuclear Medicine: The Requisites, pp. 93-128. Mosby Year Book, St. Louis.
28. 99mTc-Sn-EHDP. J. Nucl. Med. 13, 472.
29. Watts N. B. (1994) Treatment of osteoporosis with bisphosphonate. Rheum. Dis. Clin. North Am. 20, 17-34.
30. Yano Y., McRae J., Van Dyke D. C. and Anger H. O. (1973) Technetium-99m-labeled stannous ethane-1-hydroxy-1,1-diphophonate: New bone-scanning agent. J. Nucl. Med. 14, 72-78.
31. 99mTc-labeled Sn(II)-diphosphonate: A bone-scnning agent. J. Nucl. Med. 13, 480.